EVAg

Freeze-dried Tick Borne Encephalitis Virus, strain UVE/TBEV/2013/FR/32.11 WT-PCR, complete ORF sequence. It was produced by ISA method from infectious clone derived from Oshima 5.10 strain (genbank sequence KF623542)

Freeze-dried Tick-borne encephalitis virus, strain UVE/TBEV/2013/FR/32.11 ɸNS5-PCR, partial sequence.

Freeze-dried Tick-borne encephalitis virus, strain UVE/TBEV/2013/FR/32.11 ɸNS3 ɸNS5-PCR, complete ORF sequence.

Freeze-dried Barmah Forest virus, strain UVE/BFV/UNK/XX, partial sequence

Freeze-dried Yellow fever virus, strain UVE/YFV/1940/SD/M 90-5 TVP 3230, Sudan 1940, complete ORF sequence

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the N (CUB) gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

RNA extracted from infected cell culture supernatant.

RNA extracted from infected cell culture supernatant of Pirital virus. Virus Provenance: Venezuela

RNA extracted from infected cell culture supernatant of Parana virus, Paraguay, 1966

RNA extracted from infected cell culture supernatant of Tacaribe virus

RNA extracted from infected cell culture supernatant of Bear Canyon virus, USA, 1998,

RNA extracted from infected cell culture supernatant of Oliveros Virus, Argentina, 1990

RNA extracted from infected cell culture supernatant of Pichinde virus. Virus Provenance Colombia, 1965,

RNA extracted from infected cell culture supernatant of Tamiami virus

RNA extracted from infected cell culture supernatant of Cupixi virus, Brazil

Freeze-dried Mammalian orthoreovirus 4, strain Ndelle v. Cameroon, complete ORF sequence.

RNA extracted from infected cell culture supernatant.

Freeze-dried Mammalian orthoreovirus 3, strain Dearing 824-VR, partial sequence.

Freeze dried West Nile virus, strain UVE/WNV/UNK/EG/Egypt 101, Egypt, partial sequence.

RNA extracted from infected cell culture supernatant. Virus Provenance: St Martin, French Caribbean

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp gene, for 25 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the E gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)